[Gene therapy in autoimmune rheumatic diseases]. 1999

I Sekigawa, and H Ogasawara, and S Hirose
Department of Medicine, Juntendo University Izu-Nagaoka Hospital.

Several investigators have reported the possibility of gene therapy for experimental autoimmune diseases such as type-1 insulin-dependent diabetes (IDDM), experimental allergic encephalomyelitis (EAE), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE). Although there are no reports about gene therapies for human autoimmune rheumatic diseases including RA and SLE, we reviewed these experimental therapies for model animals and discussed the possibility of gene therapy for human autoimmune rheumatic disorders as a new therapeutic strategy.

UI MeSH Term Description Entries
D003095 Collagen Diseases Historically, a heterogeneous group of acute and chronic diseases, including rheumatoid arthritis, systemic lupus erythematosus, progressive systemic sclerosis, dermatomyositis, etc. This classification was based on the notion that "collagen" was equivalent to "connective tissue", but with the present recognition of the different types of collagen and the aggregates derived from them as distinct entities, the term "collagen diseases" now pertains exclusively to those inherited conditions in which the primary defect is at the gene level and affects collagen biosynthesis, post-translational modification, or extracellular processing directly. (From Cecil Textbook of Medicine, 19th ed, p1494) Collagen Disease,Disease, Collagen,Diseases, Collagen
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005544 Forecasting The prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology. Futurology,Projections and Predictions,Future,Predictions and Projections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D015316 Genetic Therapy Techniques and strategies which include the use of coding sequences and other conventional or radical means to transform or modify cells for the purpose of treating or reversing disease conditions. Gene Therapy,Somatic Gene Therapy,DNA Therapy,Gene Therapy, Somatic,Genetic Therapy, Gametic,Genetic Therapy, Somatic,Therapy, DNA,Therapy, Gene,Therapy, Somatic Gene,Gametic Genetic Therapies,Gametic Genetic Therapy,Genetic Therapies,Genetic Therapies, Gametic,Genetic Therapies, Somatic,Somatic Genetic Therapies,Somatic Genetic Therapy,Therapies, Gametic Genetic,Therapies, Genetic,Therapies, Somatic Genetic,Therapy, Gametic Genetic,Therapy, Genetic,Therapy, Somatic Genetic

Related Publications

I Sekigawa, and H Ogasawara, and S Hirose
December 2005, Reumatologia clinica,
I Sekigawa, and H Ogasawara, and S Hirose
December 2001, Best practice & research. Clinical rheumatology,
I Sekigawa, and H Ogasawara, and S Hirose
March 1998, Annals of the rheumatic diseases,
I Sekigawa, and H Ogasawara, and S Hirose
January 2014, BioMed research international,
I Sekigawa, and H Ogasawara, and S Hirose
January 1993, Intervirology,
I Sekigawa, and H Ogasawara, and S Hirose
January 1999, Arthritis and rheumatism,
I Sekigawa, and H Ogasawara, and S Hirose
October 2004, Current opinion in molecular therapeutics,
I Sekigawa, and H Ogasawara, and S Hirose
August 2013, Lancet (London, England),
I Sekigawa, and H Ogasawara, and S Hirose
January 2002, Journal of the American Pharmaceutical Association (Washington, D.C. : 1996),
I Sekigawa, and H Ogasawara, and S Hirose
March 2012, Reumatismo,
Copied contents to your clipboard!